Form 8-K - Current report:
SEC Accession No. 0001104659-21-100444
Filing Date
2021-08-05
Accepted
2021-08-05 07:45:50
Documents
1
Period of Report
2021-08-04
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2123993d1_8k.htm 8-K 21030
  Complete submission text file 0001104659-21-100444.txt   22312
Mailing Address ONE MAIN STREET, 10TH FLOOR CAMBRIDGE MA 02142
Business Address ONE MAIN STREET, 10TH FLOOR CAMBRIDGE MA 02142 617-417-5868
Black Diamond Therapeutics, Inc. (Filer) CIK: 0001701541 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39200 | Film No.: 211146364
SIC: 2836 Biological Products, (No Diagnostic Substances)